CardiacAssist receives FDA IDE approval for TandemHeart pivotal trial

December 19, 2012 by MassDevice staff

The FDA gives CardiacAssist Investigational Device Exemption approval for a pivotal clinical study of the TandemHeart circulatory support system.

CardiacAssist logo

Pittsburgh-based medical device maker CardiacAssist received Investigational Device Exemption approval from the FDA to begin a pivotal clinical study of its TandemHeart circulatory support system.

The TandemHeart to Reduce Infarct Size trial will evaluate the effectiveness of ventricular unloading on the reduction of infarct size for patients with severe heart attack, according to the press release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp